In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories.
about
Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activityScaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide componentIn vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicideInvestigation of griffithsin's interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidateCandidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants.Development of topical microbicides to prevent the sexual transmission of HIVIdentification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitroSafety and anti-HIV assessments of natural vaginal cleansing products in an established topical microbicides in vitro testing algorithm.Establishment and characterization of a differentiated epithelial cell culture model derived from the porcine cervix uteri.Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infectionIn vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides.Use of human mucosal tissue to study HIV-1 pathogenesis and evaluate HIV-1 prevention modalities.Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture.Factors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1Microbicides for the Treatment of Sexually Transmitted HIV Infections.The nonnucleoside reverse transcription inhibitor MIV-160 delivered from an intravaginal ring, but not from a carrageenan gel, protects against simian/human immunodeficiency virus-RT Infection.Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides.Culturing and applications of rotating wall vessel bioreactor derived 3D epithelial cell models.An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV TransmissionMicrobicides: still a long road to successExtracts from Acacia catechu suppress HIV-1 replication by inhibiting the activities of the viral protease and Tat.Update on nonoxynol-9 as vaginal spermicide.The future of HIV microbicides: challenges and opportunities.Nonoxynol-9 berberine plural gel has little effect on expression of SLPI, SP-D and lactoferrin in mice's vagina.MIV-150-containing intravaginal rings protect macaque vaginal explants against SHIV-RT infection.Current and future microbicide approaches aimed at preventing HIV infection in women.A dual-chamber model of the female genital tract to evaluate epithelial toxicity of candidate anti-HIV microbicides.Critical design features of phenyl carboxylate-containing polymer microbicides.Development and characterization of a three-dimensional organotypic human vaginal epithelial cell model.An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development.
P2860
Q21133918-82B23D26-2027-4E06-83A8-06B1E6003C3EQ24650458-8908165A-003D-4DB6-8652-61AB9DB5D128Q28472968-E6AEEDFC-41C0-4783-829B-5DD227A6D3BDQ28741890-C47BB1FD-163A-4153-85A5-CC0E3B504E74Q30356032-8189403C-7C54-4273-9769-522BF8006873Q33625073-B95961AC-7D2D-41AC-82AE-73FA4F159B84Q34025707-3FDE3FF8-ABDE-44C1-BA70-A8A63932BCB2Q34035880-5F6DD421-AC0D-4AA5-880D-259BE0C5EEAFQ34202026-FD2FE994-5894-43B1-A042-8150DA03D339Q34285096-053FAE9A-1ECD-4BB9-AAAA-5EF90705B5C6Q34309533-9601BF4D-E4EC-4CC7-B6B4-6638A2C5C77FQ34566597-39CA9641-9793-4A1A-A9CE-BD3FE28E0BF8Q35618379-DE286FD4-00A8-422F-A700-0BBCEDB0C442Q35759112-6EFDB53E-D93E-456D-AAF8-552D00D25C54Q36111516-1C74D526-2DBB-44FE-86A2-FC1C7DC2CC83Q36112191-027DBAAB-48B2-4F02-B94F-0B356F8F5F27Q36359133-55FA54FA-B271-4687-A4CC-CAD1C763D8D1Q36593791-DB9F87AE-70AD-46D0-9259-AE199918BB14Q36594787-55B43DD5-35EB-42DD-9FDE-E70DDF40E4FBQ36770118-17A17F0B-5C04-4594-90B0-0145BF922FBEQ37130757-2E2B1532-2BCD-4373-8AEC-3C04FDA85042Q37285671-C6DB1657-1ACC-4F8B-AB21-F782239D79C3Q37360574-28894421-6268-4F89-84E0-13A5BF848E95Q37448790-A8A5C6EE-E790-48A2-878F-CFD54B231D66Q37615377-18457A6C-7F65-4CB7-91DD-ECE635EA41FEQ37713059-BD6C40D7-1303-4B27-8B88-801FDA6C0736Q37984498-C60F78F1-2779-487F-98BC-71DF0F460906Q38879638-DA3BA410-E1C0-4757-B53F-D6408D4AE9E3Q39383159-410F2BC2-1F3F-4B51-B98B-235EFF623A3DQ39763796-F9A3E3DE-7D08-4F5F-BC0B-DE762DC2975BQ55516259-185971F9-3437-41BB-88AC-EA253015411A
P2860
In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
In vitro preclinical testing o ...... esults from five laboratories.
@ast
In vitro preclinical testing o ...... esults from five laboratories.
@en
In vitro preclinical testing o ...... esults from five laboratories.
@nl
type
label
In vitro preclinical testing o ...... esults from five laboratories.
@ast
In vitro preclinical testing o ...... esults from five laboratories.
@en
In vitro preclinical testing o ...... esults from five laboratories.
@nl
prefLabel
In vitro preclinical testing o ...... esults from five laboratories.
@ast
In vitro preclinical testing o ...... esults from five laboratories.
@en
In vitro preclinical testing o ...... esults from five laboratories.
@nl
P2093
P2860
P1476
In vitro preclinical testing o ...... esults from five laboratories.
@en
P2093
Bradley J Catalone
Brian Wigdahl
Brigitte E Beer
Carol Lackman-Smith
Charlene S Dezzutti
Clay Osterling
Ena Bromley
Fred C Krebs
Gustavo F Doncel
James E Cummins
P2860
P304
P356
10.1128/AAC.50.2.713-723.2006
P407
P577
2006-02-01T00:00:00Z